Skip to main content
SpringerLink
Log in

Primary Ovarian Insufficiency

  • Chapter
  • First Online:
Menopause

Abstract

Premature ovarian insufficiency (POI) can be defined as a cessation of ovarian function in women younger than 40 years old and is linked to the development of hypergonadotropic hypogonadism. The hypogonadism clinically presents as amenorrhea, which sometimes is preceded by oligomenorrhea and decreased circulating estradiol levels. Different clinical definitions of POI have been proposed (see below).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Cooper AR, Baker VL, Sterling EW, Ryan ME, Woodruff TK, Nelson LM. The time is now for a new approach to primary ovarian insufficiency. Fertil Steril. 2011;95:1890–7.

    Article  PubMed  Google Scholar 

  2. European Society for Human Reproduction and Embryology (ESHRE) Guideline Group on POI, Webber L, Davies M, Anderson R, Bartlett J, Braat D, Cartwright B, Cifkova R, de Muinck Keizer-Schrama S, Hogervorst E, Janse F, Liao L, Vlaisavljevic V, Zillikens C, Vermeulen N. ESHRE guideline: management of women with premature ovarian insufficiency. Hum Reprod. 2016;31(5):926–37.

    Article  Google Scholar 

  3. Kalantari H, Madani T, Zari Moradi S, Mansouri Z, Almadani N, Gourabi H, Mohseni Meybodi A. Cytogenetic analysis of 179 Iranian women with premature ovarian failure. Gynecol Endocrinol. 2013;29:588–91.

    Article  PubMed  Google Scholar 

  4. Meczekalski B, Podfigurna-Stopa A. Genetics of premature ovarian failure. Minerva Endocrinol. 2010;35(4):195–209.

    CAS  PubMed  Google Scholar 

  5. Dube JL, Wang P, Elvin J, Lyons KM, Celeste AJ, Matzuk MM. The bone morphogenetic protein 15 gene is X-linked and expressed in oocytes. Mol Endocrinol. 1998;12:1809–17.

    Article  CAS  PubMed  Google Scholar 

  6. Di Pasquale E, Beck-Peccoz P, Persani L. Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15 (BMP15) gene. Am J Hum Genet. 2004;75:106–11.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Knight PG, Glister C. TGF-beta superfamily members and ovarian follicle development. Reproduction. 2006;132:191–206.

    Article  CAS  PubMed  Google Scholar 

  8. Laissue P, Christin-Maitre S, Touraine P, Kuttenn F, Ritvos O, Aittomaki K, Bourcigaux N, Jacquesson L, Bouchard P, Frydman R, Dewailly D, Reyss AC, Jeffery L, Bachelot A, Massin N, Fellous M, Veitia RA. Mutations and sequence variants in GDF9 and BMP15 in patients with premature ovarian failure. Eur J Endocrinol. 2006;154(5):739–44.

    Article  CAS  PubMed  Google Scholar 

  9. Takebayashi K, Takakura K, Wang H, Kimura F, Kasahara K, Noda Y. Mutation analysis of the growth differentiation factor-9 and -9B genes in patients with premature ovarian failure and polycystic ovary syndrome. Fertil Steril. 2000;74:976–9.

    Article  CAS  PubMed  Google Scholar 

  10. MacNaughton J, Banah M, McCloud P, Hee J, Burger H. Age related changes in follicle stimulating hormone, luteinizing hormone, oestradiol and immunoreactive inhibin in women of reproductive age. Clin Endocrinol. 1992;36:339–45.

    Article  CAS  Google Scholar 

  11. Shelling AN, Burton KA, Chand AL, van Ee CC, France JT, Farquhar CM, et al. Inhibin: a candidate gene for premature ovarian failure. Hum Reprod. 2000;15:2644–9.

    Article  CAS  PubMed  Google Scholar 

  12. Marozzi A, Porta C, Vegetti W, Crosignani PG, Tibiletti MG, Dalprà L, et al. Mutation analysis of the inhibin alpha gene in a cohort of Italian women affected by ovarian failure. Hum Reprod. 2002;17:1741–5.

    Article  CAS  PubMed  Google Scholar 

  13. Rah H, Jeon YJ, Ko JJ, Kim JH, Kim YR, Cha SH, Choi Y, Lee WS, Kim NK. Association of inhibin α gene promoter polymorphisms with risk of idiopathic primary ovarian insufficiency in Korean women. Maturitas. 2014;77(2):163–7.

    Article  CAS  PubMed  Google Scholar 

  14. Verkerk AJ, Pieretti M, Sutcliffe JS, Fu YH, Kuhl DP, Pizzuti A, et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell. 1991;65:905–14.

    Article  CAS  PubMed  Google Scholar 

  15. Oostra BA, Willemsen R. FMR1: a gene with three faces. Biochim Biophys Acta. 2009;1790:467–77.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Murray A, Schoemaker MJ, Bennett CE, Ennis S, Macpherson JN, Jones M, Morris DH, Orr N, Ashworth A, Jacobs PA, Swerdlow AJ. Population- based estimates of the prevalence of FMR1 expansion mutations in women with early menopause and primary ovarian insufficiency. Genet Med. 2014;16:19–24.

    Article  CAS  PubMed  Google Scholar 

  17. Marchese A, Docherty JM, Nguyen T, Heiber M, Cheng R, Heng HH, et al. Cloning of human genes encoding novel G protein-coupled receptors. Genomics. 1994;23:609–18.

    Article  CAS  PubMed  Google Scholar 

  18. Mehlmann LM, Saeki Y, Tanaka S, Brennan TJ, Evsikov AV, Pendola FL, et al. The Gs-linked receptor GPR3 maintains meiotic arrest in mammalian oocytes. Science. 2004;306:1947–50.

    Article  CAS  PubMed  Google Scholar 

  19. Zhou S, Wang B, Ni F, Wang J, Cao Y, Ma X. GPR3 may not be a potential candidate gene for premature ovarian failure. Reprod Biomed Online. 2010;20(1):53–5.

    Article  CAS  PubMed  Google Scholar 

  20. Kovanci E, Simpson JL, Amato P, Rohozinski J, Heard MJ, Bishop CE, Carson SA. Oocyte-specific G-protein-coupled receptor 3 (GPR3): no perturbations found in 82 women with premature ovarian failure (first report). Fertil Steril. 2008;90(4):1269–71.

    Article  CAS  PubMed  Google Scholar 

  21. Köhler B, Lin L, Ferraz-de-Souza B, Wieacker P, Heidemann P, Schröder V, et al. Five novel mutations in steroidogenic factor 1 (SF1, NR5A1) in 46,XY patients with severe underandrogenization but without adrenal insufficiency. Hum Mutat. 2008;29:59–64.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  22. Lourenço D, Brauner R, Lin L, De Perdigo A, Weryha G, Muresan M, et al. Mutations in NR5A1 associated with ovarian insufficiency. N Engl J Med. 2009;360:1200–10.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  23. Brenkman AB, Burgering BM. FoxO3a eggs on fertility and aging. Trends Mol Med. 2003;9:464–7.

    Article  CAS  PubMed  Google Scholar 

  24. Watkins WJ, Umbers AJ, Woad KJ, Harris SE, Winship IM, Gersak K, et al. Mutational screening of FOXO3A and FOXO1A in women with premature ovarian failure. Fertil Steril. 2006;86:1518–21.

    Article  CAS  PubMed  Google Scholar 

  25. Qin Y, Choi Y, Zhao H, Simpson JL, Chen ZJ, Rajkovic A. NOBOX homeobox mutation causes premature ovarian failure. Am J Hum Genet. 2007;81:576–81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Qin Y, Shi Y, Zhao Y, Carson SA, Simpson JL, Chen ZJ. Mutation analysis of NOBOX homeodomain in Chinese women with premature ovarian failure. Fertil Steril. 2009;91:1507–9.

    Article  CAS  PubMed  Google Scholar 

  27. Bouilly J, Veitia RA, Binart N. NOBOX is a key FOXL2 partner involved in ovarian folliculogenesis. J Mol Cell Biol. 2014;6(2):175–7.

    Article  PubMed  Google Scholar 

  28. Soyal SM, Amleh A, Dean J. FIGalpha, a germ cell-specific transcription factor required for ovarian follicle formation. Development. 2000;127:645–54.

    Google Scholar 

  29. Zhao H, Chen ZJ, Qin Y, Shi Y, Wang S, Choi Y, et al. Transcription factor FIGLA is mutated in patients with premature ovarian failure. Am J Hum Genet. 2008;82:1342–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Tosh D, Rani HS, Murty US, Deenadayal A, Grover P. Mutational analysis of the FIGLA gene in women with idiopathic premature ovarian failure. Menopause. 2015;22(5):520–6.

    Article  PubMed  Google Scholar 

  31. Sybert VP, McCauley E. Turner syndrome. N Engl J Med. 2004;351:1227–38.

    Article  CAS  PubMed  Google Scholar 

  32. Schachter H, Freeze HH. Glycosylation diseases: quo vadis? Biochim Biophys Acta. 2009;1792:925–30.

    Article  CAS  PubMed  Google Scholar 

  33. Laml T, Preyer O, Umek W, Hengstschlager M, Hanzal H. Genetic disorders in premature ovarian failure. Hum Reprod Update. 2002;8:483–91.

    Article  CAS  PubMed  Google Scholar 

  34. Banerjee S, Chakraborty P, Saha P, Bandyopadhyay SA, Banerjee S, Kabir SN. Ovotoxic effects of galactose involve attenuation of follicle-stimulating hormone bioactivity and up-regulation of granulosa cell p53 expression. PLoS One. 2012;2:e30709.

    Article  CAS  Google Scholar 

  35. Albright F, Burnett CH, Smith PH, Parson W. Pseudohypoparathyroidism—an example of ‘Seabright-Bantam Syndrome’. Endocrinology. 1942;30:922–32.

    CAS  Google Scholar 

  36. Mantovani G, Ballare E, Giammona E, Beck-Peccoz P, Spada A. The gsalpha gene: predominant maternal origin of transcription in human thyroid gland and gonads. J Clin Endocrinol Metab. 2002;87:4736–40.

    Article  CAS  PubMed  Google Scholar 

  37. Alimohammadi M, Bjorklund P, Hallgren A, et al. Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen. N Engl J Med. 2008;358:1018–28.

    Article  CAS  PubMed  Google Scholar 

  38. Eisenbarth GS, Gottlieb PA. Autoimmune polyendocrine syndromes. N Engl J Med. 2004;350:2068–79.

    Article  CAS  PubMed  Google Scholar 

  39. Yu Wai Man CY, Smith T, Chinnery PF, Turnbull DM, Griffiths PG. Assessment of visual function in chronic progressive external ophthalmoplegia. Eye (Lond). 2006;20:564–8.

    Article  CAS  Google Scholar 

  40. Pagnamenta AT, Taanman JW, Wilson CJ, Anderson NE, Marotta R, Duncan AJ, et al. Dominant inheritance of premature ovarian failure associated with mutant mitochondrial DNA polymerase gamma. Hum Reprod. 2006;21:2467–73.

    Article  CAS  PubMed  Google Scholar 

  41. Schiffmann R, Tedeschi G, Kinkel RP, Trapp BD, Frank JA, Kaneski CR, Brady RO, Barton NW, Nelson L, Yanovski JA. Leukodystrophy in patients with ovarian dysgenesis. Ann Neurol. 1997;41:654–61.

    Article  CAS  PubMed  Google Scholar 

  42. Fogli A, Schiffmann R, Bertini E, Ughetto S, Combes P, Eymard-Pierre E, et al. The effect of genotype on the natural history of eIF2B-related leukodystrophies. Neurology. 2004;62:1509–17.

    Article  CAS  PubMed  Google Scholar 

  43. Mavrou A, Tsangaris GT, Roma E, Kolialexi A. The ATM gene and ataxia telangiectasia. Anticancer Res. 2008;28:401–5.

    CAS  PubMed  Google Scholar 

  44. Frappart PO, McKinnon PJ. Ataxia-telangiectasia and related diseases. NeuroMolecular Med. 2006;8:495–511.

    Article  CAS  PubMed  Google Scholar 

  45. Christin-Maitre S, Vasseur C, Portnoï MF, Bouchard P. Genes and premature ovarian failure. Mol Cell Endocrinol. 1998;145:75–80.

    Article  CAS  PubMed  Google Scholar 

  46. Kornak U, Mundlos S. Genetic disorders of the skeleton: a developmental approach. Am J Hum Genet. 2003;73:447–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Demirhan O, Türkmen S, Schwabe GC, Soyupak S, Akgül E, Tastemir D, et al. A homozygous BMPR1B mutation causes a new subtype of acromesomelic chondrodysplasia with genital anomalies. J Med Genet. 2005;42:314–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Crisponi L, Deiana M, Loi A, Chiappe F, Uda M, Amati P, et al. The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome. Nat Genet. 2001;27:159–66.

    Article  CAS  PubMed  Google Scholar 

  49. De Baere E, Lemercier B, Christin-Maitre S, Durval D, Messiaen L, Fellous M, Veitia R. FOXL2 mutation screening in a large panel of POF patients and XX males. J Med Genet. 2002;8:e43.

    Article  Google Scholar 

  50. Rubio-Gozalbo M, Gubbels C, Bakker J, Menheere P, Wodzig W, Land J. Gonadal function in male and female patients with classic galactosemia. Hum Reprod Update. 2010;16:177–88.

    Article  CAS  PubMed  Google Scholar 

  51. Ryan EL, Lynch ME, Taddeo E, Gleason TJ, Epstein MP, Fridovich-Keil JL. Cryptic residual GALT activity is a potential modifier of scholastic outcome in school age children with classic galactosemia. J Inherit Metab Dis. 2013;36:1049–61.

    Article  PubMed  Google Scholar 

  52. Kokcu A. Premature ovarian failure from current perspective. Gynecol Endocrinol. 2010;26:555–62.

    Article  PubMed  Google Scholar 

  53. Arora RS, Alston RD, Eden TO, Moran A, Geraci M, O’Hara C, Birch JM. Cancer at ages 15-29 years: the contrasting incidence in India and England. Pediatr Blood Cancer. 2012;58(1):55–60.

    Article  PubMed  Google Scholar 

  54. Chhabra S, Kutchi I. Fertility preservation in gynecological cancers. Clin Med Insights Reprod Health. 2013;7:49–59.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Ajala T, Rafi J, Larsen-Disney P, Howell R. Fertility preservation for cancer patients: a review. Obstet Gynecol Int. 2010;2010:160386.

    PubMed  PubMed Central  Google Scholar 

  56. Coccia ME, Rizzello F, Mariani G, Bulletti C, Palagiano A, Scarselli G. Ovarian surgery for bilateral endometriomas influences age at menopause. Hum Reprod. 2011;26(11):3000–7.

    Article  PubMed  Google Scholar 

  57. Haller-Kikkatalo K, Uibo R, Kurg A, Salumets A. The prevalence and phenotypic characteristics of spontaneous premature ovarian failure: a general population registry-based study. Hum Reprod. 2015;30(5):1229–38. doi:10.1093/humrep/dev021. Epub 2015 Feb 23

    Article  CAS  PubMed  Google Scholar 

  58. Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol. 1986;67:604–6.

    CAS  PubMed  Google Scholar 

  59. Luborsky JL, Meyer P, Sowers MF, Gold EB, Santoro N. Premature menopause in a multi-ethnic population study of the menopause transition. Hum Reprod. 2003;18:199–206.

    Article  CAS  PubMed  Google Scholar 

  60. Wu X, Cai H, Kallianpur A, Li H, Yang G, Gao J, Xiang YB, Ji BT, Yu T, Zheng W, Shu XO. Impact of premature ovarian failure on mortality and morbidity among Chinese women. PLoS One. 2014;9:e89597.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  61. Gold EB, Crawford SL, Avis NE, Crandall CJ, Matthews KA, Waetjen LE, Lee JS, Thurston R, Vuga M, Harlow SD. Factors related to age at natural menopause: longitudinal analyses from SWAN. Am J Epidemiol. 2013;178:70–83.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Ferrarini E, Russo L, Fruzzetti F, Agretti P, De Marco G, Dimida A, Gianetti E, Simoncini T, Simi P, Baldinotti F, Bennelli E, Pucci E, Pinchera A, Vitti P, Tonacchera M. Clinical characteristics and genetic analysis in women with premature ovarian insufficiency. Maturitas. 2013;74:61–7.

    Article  CAS  PubMed  Google Scholar 

  63. Nelson LM. Primary ovarian insufficiency. NEJM. 2009;360:606–14.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Maclaran K, Panay N. Current concepts in premature ovarian insufficiency. Womens Health. 2015;11:169–82.

    CAS  Google Scholar 

  65. Kovanci E, Schutt AK. Premature ovarian failure. Obstet Gynecol Clin N Am. 2015;42:153–61.

    Article  Google Scholar 

  66. Cohen J, Chabbert-Buffet N, Darai E. Diminished ovarian reserve, premature ovarian failure, poor ovarian responder—a plea for universal definitions. J Assist Reprod Genet. 2015;32:1709–12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Panay N, Kalu E. Management of premature ovarian failure. Best Pract Res Clin Obstet Gynaecol. 2009;23:129–40.

    Article  PubMed  Google Scholar 

  68. Vujovic S, Brincat M, Erel T, Gambacciani M, Lambrinoudaki I, Moen MH, Schenk-Gustafsson K, Tremollieres F, Rozenberg S, Rees M. EMAS position statement: Managing women with premature ovarian failure. Maturitas. 2010;67:91–3.

    Article  PubMed  Google Scholar 

  69. Podfigurna-Stopa A, Czyżyk A, Grymowicz M, Smolarczyk R, Katulski K, Czajkowski K, Meczekalski B. Premature ovarian insufficiency: the context of long term effects. J Endocrinol Investig. 2016;39:983–90.

    Article  CAS  Google Scholar 

  70. Gleicher N, Weghofer A, Oktay K, Barad D. Do etiologies of premature ovarian aging (POA) mimic those of premature ovarian failure (POF)? Hum Reprod. 2009;24:2395–400.

    Article  CAS  PubMed  Google Scholar 

  71. Ferraretti AP, La Marca A, Fauser BCJM, Tarlatzis B, Nargund G, Gianaroli L. ESHRE consensus on the definition of “poor response” to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod. 2011;26:1616–24.

    Article  CAS  PubMed  Google Scholar 

  72. Fenton AJ. Premature ovarian insufficiency; Pathogenesis and management. J Midlife Health. 2015;6:147–53.

    PubMed  PubMed Central  Google Scholar 

  73. Bidet M, Bachelot A, Bissauge E, Golmard JL, Gricourt S, Dulon J, Coussieu C, Badachi Y, Touraine P. Resumption of ovarian function and pregnancies in 358 patients with premature ovarian failure. J Clin Endocrinol Metab. 2011;96:3864–72.

    Article  CAS  PubMed  Google Scholar 

  74. Cameron M, Grover S, Moore P, Jayasinghe Y. Non-chromosomal, non-iatrogenic premature ovarian failure in an adolescent population: a case series. J Pediatr Adolesc Gynecol. 2008;21:3–8.

    Article  PubMed  Google Scholar 

  75. Massin N, Czernichow C, Thibaud E, Kutten F, Polak M, Touraine P. Idiopathic premature ovarian failure in 63 young women. Horm Res. 2006;65:89–95.

    CAS  PubMed  Google Scholar 

  76. Dixit H, Rao L, Padmalatha V, Raseswari T, Kapu AK, Panda B, Murthy K, Tosh D, Nallari P, Deenadayal M, Gupta N, Chakrabarthy B, Singh L. Genes governing premature ovarian failure. Reprod Biomed Online. 2010;20:724–40.

    Article  CAS  PubMed  Google Scholar 

  77. Ebrahimi M, Asbagh FA. The role of autoimmunity in premature ovarian failure. Iran J Reprod Med. 2015;13:461–72.

    PubMed  PubMed Central  Google Scholar 

  78. Reato G, Morlin L, Chen S, Furmaniak J, Smith R, Masierro S, Albergoni MP, Cervato S, Zanchetta R, Betterle C. Premature ovarian failure in patients with autoimmune Addison’s disease: clinical, genetic, and immunological evaluation. J Clin Endocrinol Metab. 2011;96:E1255–61.

    Article  CAS  PubMed  Google Scholar 

  79. Szlendak-Sauer K, Jakubik D, Kunicki M, Skórska J, Smolarczyk R. Autoimmune polyglandular syndrome type 3 (APS-3) among patients with premature ovarian insufficiency (POI). Eur J Obstet Gynecol Reprod Biol. 2016;203:61–5.

    Article  CAS  PubMed  Google Scholar 

  80. van Dorp W, Mulder RL, Kremer LCM, et al. Recommendations for premature ovarian insufficiency surveillance for female survivors of childhood, adolescent, and young adult cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium. J Clin Oncol. 2016;34:3440–50.

    Article  PubMed  PubMed Central  Google Scholar 

  81. Mehta AE, Matwijiw I, Lyons EA, Faiman C. Noninvasive diagnosis of resistant ovary syndrome by ultrasonography. Fertil Steril. 1992;57:56–61.

    Article  CAS  PubMed  Google Scholar 

  82. Knauff EAH, Eijkemans MJC, Lambalk CB, et al. Anti-mullerian hormone, inhibin B, and antral follicle count in young women with ovarian failure. J Clin Endocrinol Metab. 2009;94:786–92.

    Article  CAS  PubMed  Google Scholar 

  83. Massin N, Gougeon A, Meduri G, et al. Significance of ovarian histology in the management of patients presenting a premature ovarian failure. Hum Reprod. 2004;19:2555–60.

    Article  CAS  PubMed  Google Scholar 

  84. Abe N, Takeuchi H, Kikuchi I, et al. Effectiveness of minilaparoscopy in the diagnosis of premature ovarian failure. J Obstet Gyneaecol Res. 2006;32:224–9.

    Article  Google Scholar 

  85. Hirota Y, Ohara S, Nishizawa H, et al. Evaluation of laparoscopic management and clinical outcome in women with premature ovarian failure. Gynaecol Endosc. 2002;11:411–5.

    Article  Google Scholar 

  86. de Carvalho BR, de Sa Rosa e Silva ACJ, Rosa e Silva JC, et al. Ovarian reserve evaluation: state of the art. J Assist Reprod Genet. 2008;25:311–22.

    Article  PubMed  PubMed Central  Google Scholar 

  87. Gleicher N, Kushnir V, Barad D. Prospectively assessing risk for premature ovarian senescence in young females: a new paradigm. Reprod Biol Endocrinol. 2015;13:34.

    Article  PubMed  PubMed Central  Google Scholar 

  88. Alipour F, Rasekhjahromi A, Maalhagh M, et al. Comparison of specificity and sensitivity of AMH and FSH in diagnosis of premature ovarian failure. Dis Markers. 2015;2015:4.

    Article  CAS  Google Scholar 

  89. Massin N, Meduri G, Bachelot A, et al. Evaluation of different markers of the ovarian reserve in patients presenting with premature ovarian failure. Mol Cell Endocrinol. 2008;282:95–100.

    Article  CAS  PubMed  Google Scholar 

  90. Saglam F, Onal ED, Ersoy R, et al. Anti-mullerian hormone as a marker of premature ovarian aging in autoimmune thyroid disease. Gynecol Endocrinol. 2015;31:165–8.

    Article  CAS  PubMed  Google Scholar 

  91. Schnatz PF. The 2010 North American Menopause Society position statement: updates on screening, prevention and management of postmenopausal osteoporosis. Conn Med. 2011;75(8):485–7.

    PubMed  Google Scholar 

  92. Popat VB, Calis KA, Vanderhoof VH, Cizza G, Reynolds JC, Sebring N, Troendle JF, Nelson LM. Bone mineral density in estrogen-deficient young women. J Clin Endocrinol Metab. 2009;94(7):2277–83.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  93. Banks E, Reeves GK, Beral V, Balkwill A, Liu B, Roddam A, Million Women Study Collaborators. Hip fracture incidence in relation to age, menopausal status, and age at menopause: prospective analysis. PLoS Med. 2009;6(11):e1000181.

    Article  PubMed  PubMed Central  Google Scholar 

  94. Manolagas SC, O’Brien CA, Almeida M. The role of estrogen and androgen receptors in bone health and disease. Nat Rev Endocrinol. 2013;9(12):699–712.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  95. Albright F, Smith P, Richardson AM. Postmenopausal osteoporosis: its clinical features. JAMA. 1941;116:2465–74.

    Article  Google Scholar 

  96. Lana MB, Straminsky V, Onetto C, Amuchastegui JM, Blanco G, Galluzzo L, Provenzano S, Nolting M. What is really responsible for bone loss in spontaneous premature ovarian failure? A new enigma. Gynecol Endocrinol. 2010;26(10):755–9.

    Article  CAS  PubMed  Google Scholar 

  97. Uygur D, Sengül O, Bayar D, Erdinç S, Batioğlu S, Mollamahmutoglu L. Bone loss in young women with premature ovarian failure. Arch Gynecol Obstet. 2005;273(1):17–9.

    Article  PubMed  Google Scholar 

  98. Popat VB, Calis KA, Kalantaridou SN, Vanderhoof VH, Koziol D, Troendle JF, Reynolds JC, Nelson LM. Bone mineral density in young women with primary ovarian insufficiency: results of a three-year randomized controlled trial of physiological transdermal estradiol and testosterone replacement. J Clin Endocrinol Metab. 2014;99(9):3418–26.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  99. Leite-Silva P, Bedone A, Pinto-Neto AM, Costa JV, Costa-Paiva L. Factors associated with bone density in young women with karyotypically normal spontaneous premature ovarian failure. Arch Gynecol Obstet. 2009;280(2):177–81.

    Article  PubMed  Google Scholar 

  100. van Der Voort DJ, van Der Weijer PH, Barentsen R. Early menopause: increased fracture risk at older age. Osteoporos Int. 2003;14(6):525–30.

    Article  Google Scholar 

  101. Yorgun H, Tokgözoğlu L, Canpolat U, Gürses KM, Bozdağ G, Yapıcı Z, Sahiner L, Kaya EB, Kabakçı G, Oto A, Tuncer M, Aytemir K. The cardiovascular effects of premature ovarian failure. Int J Cardiol. 2013;168(1):506–10.

    Article  PubMed  Google Scholar 

  102. Kalantaridou SN, Naka KK, Papanikolaou E, Kazakos N, Kravariti M, Calis KA, Paraskevaidis EA, Sideris DA, Tsatsoulis A, Chrousos GP, Michalis LK. Impaired endothelial function in young women with premature ovarian failure: normalization with hormone therapy. J Clin Endocrinol Metab. 2004;89(8):3907–13.

    Article  CAS  PubMed  Google Scholar 

  103. Goldmeier S, De Angelis K, Rabello Casali K, Vilodre C, Consolim-Colombo F, Belló Klein A, Plentz R, Spritzer P, Irigoyen MC. Cardiovascular autonomic dysfunction in primary ovarian insufficiency: clinical and experimental evidence. Am J Transl Res. 2013;6(1):91–101.

    PubMed  PubMed Central  Google Scholar 

  104. Knauff EA, Westerveld HE, Goverde AJ, Eijkemans MJ, Valkenburg O, van Santbrink EJ, Fauser BC, van der Schouw YT. Lipid profile of women with premature ovarian failure. Menopause. 2008;15(5):919–23.

    Article  PubMed  Google Scholar 

  105. Daan NM, Muka T, Koster MP, Roeters van Lennep JE, Lambalk CB, Laven JS, Fauser CG, Meun C, de Rijke YB, Boersma E, Franco OH, Kavousi M, Fauser BC. Cardiovascular risk in women with premature ovarian insufficiency compared to premenopausal women at middle age. J Clin Endocrinol Metab. 2016;101(9):3306–15.

    Article  CAS  PubMed  Google Scholar 

  106. Gulhan I, Bozkaya G, Uyar I, Oztekin D, Pamuk BO, Dogan E. Serum lipid levels in women with premature ovarian failure. Menopause. 2012;19(11):1231–4.

    Article  PubMed  Google Scholar 

  107. Ates S, Yesil G, Sevket O, Molla T, Yildiz S. Comparison of metabolic profile and abdominal fat distribution between karyotypically normal women with premature ovarian insufficiency and age matched controls. Maturitas. 2014;79(3):306–10.

    Article  PubMed  Google Scholar 

  108. Kulaksizoglu M, Ipekci SH, Kebapcilar L, Kebapcilar AG, Korkmaz H, Akyurek F, Baldane S, Gonen MS. Risk factors for diabetes mellitus in women with primary ovarian insufficiency. Biol Trace Elem Res. 2013;154(3):313–20.

    Article  CAS  PubMed  Google Scholar 

  109. Jacobsen BK, Knutsen SF, Fraser GE. Age at natural menopause and total mortality and mortality from ischemic heart disease: the Adventist Health Study. J Clin Epidemiol. 1999;52:303–7.

    Article  CAS  PubMed  Google Scholar 

  110. Tao XY, Zuo AZ, Wang JQ, Tao FB. Effect of primary ovarian insufficiency and early natural menopause on mortality: a meta-analysis. Climacteric. 2016;19(1):27–36.

    Article  PubMed  Google Scholar 

  111. Roeters van Lennep JE, Heida KY, Bots ML, Hoek A. Cardiovascular disease risk in women with premature ovarian insufficiency: a systematic review and meta-analysis. Eur J Prev Cardiol. 2016;23(2):178–86.

    Article  PubMed  Google Scholar 

  112. Schmidt PJ, Cardoso GM, Ross JL, Haq N, Rubinow DR, Bondy CA. Shyness, social anxiety, and impaired self-esteem in Turner syndrome and premature ovarian failure. JAMA. 2006;295:1374–6.

    Article  CAS  PubMed  Google Scholar 

  113. National Collaborating Centre for Mental Health (UK). Depression in adults with a chronic physical health problem: treatment and management. Leicester: British Psychological Society; 2010.

    Google Scholar 

  114. Schmidt PJ, Luff JA, Haq NA, Vanderhoof VH, Koziol DE, Calis KA, Rubinow DR, Nelson LM. Depression in women with spontaneous 46, XX primary ovarian insufficiency. J Clin Endocrinol Metab. 2011;96(2):E278–87.

    Article  CAS  PubMed  Google Scholar 

  115. Liao KL, Wood N, Conway GS. Premature menopause and psychological well-being. J Psychosom Obstet Gynaecol. 2000;21(3):167–74.

    Article  CAS  PubMed  Google Scholar 

  116. Jacobsen BK, Heuch I, Kvåle G. Age at natural menopause and all-cause mortality: a 37-year follow-up of 19,731 Norwegian women. Am J Epidemiol. 2003;157(10):923–9.

    Article  PubMed  Google Scholar 

  117. Mondul AM, Rodriguez C, Jacobs EJ, Calle EE. Age at natural menopause and cause-specific mortality. Am J Epidemiol. 2005;162(11):1089–97.

    Article  PubMed  Google Scholar 

  118. Fatemi HM, Bourgain C, Donoso P, et al. Effect of oral administration of dydrogesterone versus vaginal administration of natural micronized progesterone on the secretory transformation of endometrium and luteal endocrine profile in patients with premature ovarian failure: a proof of concept. Hum Reprod. 2007;22:1260–3.

    Article  CAS  PubMed  Google Scholar 

  119. Papagianni V, Deligeoroglou E, Makrakis E, et al. Response to hormonal treatment of young females with primary or very premature ovarian failure. Gynecol Endocrinol. 2011;27:291–9.

    Article  CAS  PubMed  Google Scholar 

  120. Cartwright B, Robinson J, Seed PT, et al. Hormone replacement therapy versus the combined oral contraceptive pill in premature ovarian failure: a randomized controlled trial of the effects on bone mineral density. J Clin Endocrinol Metab. 2016;101:3497–505.

    Article  CAS  PubMed  Google Scholar 

  121. Crofton PM, Evans N, Bath LE, et al. Physiological versus standard sex steroid replacement in young women with premature ovarian failure: effects on bone mass acquisition and turnover. Clin Endocrinol. 2010;73:707–14.

    Article  CAS  Google Scholar 

  122. Pacello PCC, Yeal DA, Rabelo S, et al. Dyspareunia and lubrication in premature ovarian failure using hormonal therapy and vaginal health. Climacteric. 2014;17:342–7.

    Article  CAS  PubMed  Google Scholar 

  123. Benetti-Pinto CL, Giraldo PS, Pacello PCC, et al. Vaginal epithelium and microflora characteristics in women with premature ovarian failure under hormone therapy compared to healthy women. Arch Gynecol Obstet. 2015;292:159–64.

    Article  CAS  PubMed  Google Scholar 

  124. Davey DA. HRT: some unresolved clinical issues in breast cancer, endometrial cancer and premature ovarian insufficiency. Womens Health. 2013;9:59–67.

    CAS  Google Scholar 

  125. Ewertz M, Mellemkjaer I, Poulsen AH, et al. Hormone use for menopausal symptoms and risk of breast cancer. A Danish cohort study. Br J Cancer. 2005;92:1293–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  126. O’Donnell RL, Warner P, Lee RJ, et al. Physiological sex steroid replacement in premature ovarian failure: randomized crossover trial of effect on uterine volume, endometrial thickness and blood flow, compared with standard regimen. Hum Reprod. 2012;27:1130–8.

    Article  PubMed  CAS  Google Scholar 

  127. Bakhsh H, Dei M, Bucciantini S, et al. Premature ovarian insufficiency in young girls: repercussions on uterine volume and bone mineral density. Gynecol Endocrinol. 2015;31:65–9.

    Article  CAS  PubMed  Google Scholar 

  128. Gelbaya T, Vitthala S, Nardo L, et al. Optimizing hormone therapy for future reproductive performance in women with premature ovarian failure. Gynecol Endocrinol. 2011;27:1–7.

    Article  PubMed  Google Scholar 

  129. Lunding SA, Aksglaede L, Anderson RA, et al. AMH as predictor of premature ovarian insufficiency: a longitudinal study of 120 Turner syndrome patients. J Clin Endocrinol Metab. 2015;100:E1030–8.

    Article  CAS  PubMed  Google Scholar 

  130. Mendoza N, Julia D, Galliano D, Coronado P, Diaz B, Fontez J, Gallo JL, Garcia A, Guinot M, Munnamy M, Roca B, Sosa M, Tomas J, Llaneza P, Sanchez-Borrego R. Spanish consensus on premature menopause. Maturitas. 2015;80:220–5.

    Article  PubMed  Google Scholar 

  131. Hershlag A, Raush ME, Cohen M. Ovarian failure in adolescent cancer survivors should be treated. J Pediatr Adolesc Gynecol. 2011;24:101–3.

    Article  PubMed  Google Scholar 

  132. Fish JD. Hormone replacement for survivors of childhood cancer with ovarian failure—when is it worth the risk? J Pediatr Adolesc Gynecol. 2011;24:98–101.

    Article  PubMed  Google Scholar 

  133. Singer D, Mann E, Hunter MS, et al. The silent grief: psychological aspects of premature ovarian failure. Climacteric. 2011;14:428–37.

    Article  CAS  PubMed  Google Scholar 

  134. Groff AA, Covington SN, Lynn MSW, et al. Assessing the emotional needs of women with spontaneous premature ovarian failure. Fertil Steril. 2005;83:1734–41.

    Article  PubMed  Google Scholar 

  135. Buckman R. How to break bad news: a guide for health care professionals. Baltimore: Johns Hopkins University Press; 1992.

    Book  Google Scholar 

  136. Broner de Taraciuk M, Nolting M, Fernandez G, et al. Psychological assessment of patients with premature ovarian failure. Gynecol Endocrinol. 2008;24:44–53.

    Article  Google Scholar 

  137. Takahashi M. Psychosocial distress among young breast cancer survivors: implications for health providers. Breast Cancer. 2014;21:664–9.

    Article  PubMed  Google Scholar 

  138. Thewes B, Meiser B, Taylor A, et al. Fertility- and menopause-related information. Needs of younger women with diagnosis of early breast cancer. J Clin Oncol. 2005;22:5150–65.

    Google Scholar 

  139. Bachelot A, Nicolas C, Bidet M, et al. Long-term outcome of ovarian function in women with intermittent premature ovarian insufficiency. Clin Endocrinol. 2017;86:223–8.

    Article  Google Scholar 

  140. Robles A, Checa MA, Prat M, Carreras R. Medical alternatives to oocyte donation in women with premature ovarian failure: a systematic review. Gynecol Endocrinol. 2013;29:632–7.

    Article  PubMed  Google Scholar 

  141. Tartagni M, Cicinelli E, De Pergola G, et al. Effects of pretreatment with estrogen on ovarian stimulation with gonadotropins in women with premature ovarian failure: a randomized, placebo-controlled trial. Fertil Steril. 2007;87:858–61.

    Article  CAS  PubMed  Google Scholar 

  142. Elenis E, Svanberg AS, Lampic C, et al. Adverse obstetric outcomes in pregnancies resulting from oocyte donation: a retrospective cohort case study in Sweden. BMC Pregnancy Childbirth. 2015;15:247.

    Article  PubMed  PubMed Central  Google Scholar 

  143. Masoudian P, Nasr A, de Nanassy J, et al. Oocyte donation pregnancies and the risk of preeclampsia or gestational hypertension: a systematic review and metaanalysis. Am J Obstet Gynecol. 2016;214:328–39.

    Article  PubMed  Google Scholar 

  144. Bouet P-E, Godbout A, Hachem HE, et al. Fertility and pregnancy in Turner syndrome. J Obstet Gynaecol Can. 2016;38:712–8.

    Article  PubMed  Google Scholar 

  145. Chevalier N, Letur H, Lelannou D, Ohl J, Cornet D, Chalas-Boissonnas C, et al. Materno-fetal cardiovascular complications in Turner syndrome after oocyte donation: insufficient prepregnancy screening and pregnancy followup are associated with poor outcome. J Clin Endocrinol Metab. 2011;96:E260–7.

    Article  CAS  PubMed  Google Scholar 

  146. Hagman A, Loft A, Wennerholm UB, Pinborg A, Bergh C, Aittomäki K, et al. Obstetric and neonatal outcome after oocyte donation in 106 women with Turner syndrome: a Nordic cohort study. Hum Reprod. 2013;28:1598–609.

    Article  PubMed  Google Scholar 

  147. Cabanes L, Chalas C, Christin-Maitre S, et al. Turner syndrome and pregnancy: clinical practice. Recommendations for the management of patients with Turner syndrome before and during pregnancy. Eur J Obstet Gynecol. 2010;152:18–24.

    Article  Google Scholar 

  148. Practice Committee of the American Society for Reproductive Medicine. Increased maternal cardiovascular mortality associated with pregnancy in women with Turner syndrome. Fertil Steril. 2012;97:282–4.

    Google Scholar 

  149. Borgström B, Hreinsson J, Rasmussen C, et al. Fertility preservation in girls with Turner syndrome: prognostic signs of the presence of ovarian follicles. J Clin Endocrinol Metab. 2009;94:74–80.

    Article  PubMed  CAS  Google Scholar 

  150. Huang JYJ, Tulandi T, Holzer H, et al. Cryopreservation of ovarian tissue and in vitro matured oocytes in a female with mosaic Turner syndrome: case report. Hum Reprod. 2008;23:336–9.

    Article  CAS  PubMed  Google Scholar 

  151. Blumenfeld Z. Chemotherapy and fertility. Best Pract Res Clin Obstet Gynaecol. 2012;26:379–90.

    Article  PubMed  Google Scholar 

  152. Fastrez M, Houba C, Vandromme J, Rozenberg S. Fertility-sparing management of gynecological cancers. Maturitas. 2015;82:141–5.

    Article  CAS  PubMed  Google Scholar 

  153. Rodriguez-Wallber KA, Otkay K. Options on fertility preservation in female cancer patients. Cancer Treat Rev. 2012;38:354–61.

    Article  Google Scholar 

  154. Loren AW, Mangu PB, Beck LN, et al. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;19:2500–10.

    Article  Google Scholar 

  155. Del Masrto L, Ceppi M, Poggio F, Bighin C, Peccatori F, Demeestere I, Levaggi A, Giraudi S, Lambertini M, D’Alonzo A, Canavese G, Pronzato P, Bruzzi P. Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: Systematic review and meta-analysis of randomized trials. Cancer Treat Rev. 2014;40:675–83.

    Article  CAS  Google Scholar 

  156. Sun X, Dongol S, Jiang J, Kong B. Protection of ovarian function by GnRH agonists during chemotherapy: a meta-analysis. Int J Oncol. 2014;44:1335–40.

    Article  CAS  PubMed  Google Scholar 

  157. The Practice Committees of American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology. Mature oocyte cryopreservation: a guideline. Fertil Steril. 2013;99:37–43.

    Article  Google Scholar 

  158. Kasum M, Beketic-Oreskovic L, Peddi PF, Oreskovic S, Johnson RH. Fertility after breast cancer treatment. Eur J Obstet Gynecol Reprod Biol. 2014;173:13–8.

    Article  PubMed  Google Scholar 

  159. Cobo A, Serra V, Garrido N, Olmo I, Pellicer A, Remohi J. Obstetric and perinatal outcome of babies born from vitrified oocytes. Fertil Steril. 2014;102:1006–15.

    Article  PubMed  Google Scholar 

  160. Kim MK, Lee DR, Han JE, Kim YS, Lee WS, Won HJ, et al. Live birth with vitrified-warmed oocytes of a chronic myeloid leukemia patient nine years after allogenic bone marrow transplantation. J Assist Reprod Genet. 2011;28:1167–70.

    Article  PubMed  PubMed Central  Google Scholar 

  161. Meirow D, Ra’anani H, Shapira M, et al. Transplantations of frozen-thawed ovarian tissue demonstrate high reproductive performance and the need to revise restrictive criteria. Fertil Steril. 2016;106:467–74.

    Article  PubMed  Google Scholar 

  162. Janse F, Donnez J, Anckaert E, et al. Limited value of ovarian function markers following orthotopic transplantation of ovarian tissue after gonadotoxic treatment. J Clin Endocrinol Metab. 2011;96:1136–44.

    Article  CAS  PubMed  Google Scholar 

  163. Donnez J, Dolmans MM, Pellicer A, et al. Restoration of ovarian activity and pregnancy after transplantation of cryopreserved ovarian tissue: a review of 60 cases of reimplantation. Fertil Steril. 2013;99:1503–13.

    Article  PubMed  Google Scholar 

  164. Donnez J, Dolmans M. Transplantation of Ovarian tissue. Best Pract Res Clin Obstet Gynaecol. 2014;28:1188–97.

    Article  PubMed  Google Scholar 

  165. Dittrich R, Hackl J, Lotz L, et al. Pregnancies and live births after 20 transplantations of cryopreserved ovarian tissue in a single center. Fertil Steril. 2015;103:462–8.

    Article  PubMed  Google Scholar 

  166. Wallace WHB, Smith AG, Kelsey TW, et al. Fertility preservation for girls and young women with cancer: population-based validation of criteria for ovarian tissue cryopreservation. Lancet Oncol. 2014;15:1129–36.

    Article  PubMed  PubMed Central  Google Scholar 

  167. von Wolff M, Dittrich R, Liebenthron J, Nawroth F, Schuring AN, Bruckner T, Germeyer A. Fertility-preservation counseling and treatment for medical reasons: data from multinational network of over 5000 women. Reprod Biomed Online. 2015;31:605–12.

    Article  Google Scholar 

  168. Dalberg K, Eriksson J, Holmberg L. Birth outcome in women with previously treated breast cancer—a population based cohort study from Sweden. PLoS Med. 2006;3:1597–602.

    Article  Google Scholar 

  169. Azim HA Jr, Kroman N, Paesmans M, Gelber S, Rotmensz N, Ameye L, et al. Prognostic impact of pregnancy after breast cancer according to estrogen receptor status: a multicenter retrospective sturdy. J Clin Oncol. 2013;31:73–9.

    Article  PubMed  Google Scholar 

  170. Tomasi-Cont N, Lambertini M, Hulsbosch PAF, Amant F. Strategies for fertility preservation in young early breast cancer patients. Breast. 2014;23:503–10.

    Article  PubMed  Google Scholar 

  171. Kawamura K, Kawamura N, Hsueh AJW. Activation of dormant follicles: a new treatment for premature ovarian failure? Curr Opin Obstet Gynecol. 2016;28:217–22.

    Article  PubMed  PubMed Central  Google Scholar 

  172. Silvestris E, D’Oronzo S, Cafforio P, et al. Perspective in infertility: the ovarian stem cells. J Ovarian Res. 2015;8:55.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  173. Stimpfel M, Skutella T, Cvjeticanin B, Meznaric M, Dovc P, Novakovic S, et al. Isolation, characterization and differentiation of cells expressing pluripotent/multipotent markers from adult human ovaries. Cell Tissue Res. 2013;354:593–607.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gynecological Endocrinology, Poznan University of Medical Sciences, Poznan, Poland

    Agnieszka Podfigurna, Adam Czyzyk & Blazej Meczekalski

  2. Department of Gynecological Endocrinology, Medical University of Warsaw, Warsaw, Poland

    Monika Grymowicz & Roman Smolarczyk

Authors
  1. Agnieszka Podfigurna
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Adam Czyzyk
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Monika Grymowicz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Roman Smolarczyk
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Blazej Meczekalski
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Blazej Meczekalski .

Editor information

Editors and Affiliations

  1. Department of Pediatrics, Obstetrics and Gynecology, University of Valencia, Valencia, Spain

    Antonio Cano

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Podfigurna, A., Czyzyk, A., Grymowicz, M., Smolarczyk, R., Meczekalski, B. (2017). Primary Ovarian Insufficiency. In: Cano, A. (eds) Menopause. Springer, Cham. https://doi.org/10.1007/978-3-319-59318-0_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-59318-0_3

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-59317-3

  • Online ISBN: 978-3-319-59318-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation